FindTrial
Sign In

Siddha Treatment for Attention Deficit Hyperactivity Disorder in Children

Preclinical Validation of Muthu Parpam in Animal Model of Attention Deficit Hyperactivity Disorder (ADHD) induced by Intra Cerebro Ventricular Infusion of 6- Hydroxydopamine Hydrogen Bromide (6-OHDA HBr) and Pilot Clinical Trial in the Age Group of 7-12 Years - Preclinical & Pilot study for ADHD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105740
Enrollment
30
Registered
2026-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type

Interventions

Intervention1: Muthu Parpam: The Above mentioned medicine will be given for 45 days. Dosage is 65mg. Adjuvant is Ghee. Control Intervention1: Not Applicable: Not Applicable

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children of age group under 7-12years 2. Clinically diagnosed as a ADHD 3. Participant satisfying the DSM-5-TR Diagnostic criteria for inattention. 4. Participant satisfying the DSM-5-TR Diagnostic criteria for hyperactivity and impulsivity

Exclusion criteria

Exclusion criteria: 1. Recurrent seizure 2. cerebral palsy 3. Autistic spectrum disorder 4. congenital heart disease 5. Global Developmental delay. 6. Auditory and visual processing disorder. 7. Post-traumatic head injury. 8. Post encephalitic disorder. 9. Mental Retardation, 10. Severe and/or Multiple Disabilities

Design outcomes

Primary

MeasureTime frame
To Reduce the Behavioral Symptoms and Reduction of 1 unit of scoring in Vanderbilt ADHD Diagnostic and Rating Scale will be measured and statistically analysed.Timepoint: 45 Days—

Secondary

MeasureTime frame
Safety and efficacy of Muthu Parpam will be established from toxicity and Pharmacological studiesTimepoint: 90 days—

Countries

India

Contacts

Public ContactDr P Sasikumar

National Institute of Siddha

dramalaaruldhas@gmail.com9940429202

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026